ImatinibGrade IV bone marrow suppression: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1922卷 / 1期

关键词：

D O I：

10.1007/s40278-022-22598-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：313 / 313

相关论文

共 50 条

[31] AntineoplasticsDrug resistance, bone marrow suppression and shortness of breath: case report
Reactions Weekly, 2019, 1778 (1) : 53 - 53
[32] Carboplatin/paclitaxelIdiopathic pulmonary fibrosis and bone marrow suppression: case report
Reactions Weekly, 2023, 1951 (1) : 105 - 105
[33] Trastuzumab/oxaliplatin/capecitabineGastrointestinal reactions and bone marrow suppression: case report
Reactions Weekly, 2021, 1875 (1) : 325 - 325
[34] Bevacizumab/epirubicin/ifosfamidePulmonary embolism? and bone marrow suppression: case report
Reactions Weekly, 2013, 1475 (1) : 10 - 10
[35] Antibacterials/aspirinHaemorrhagic pericardial effusion and bone marrow suppression: case report
Reactions Weekly, 2017, 1654 (1) : 40 - 40
[36] Azathioprine/cyclophosphamide/methylprednisoloneLeucopoenia, bone marrow suppression and infection: case report
Reactions Weekly, 2021, 1876 (1) : 69 - 69
[37] ImatinibGrade 3 skin disorders: case report
Reactions Weekly, 2023, 1981 (1) : 200 - 200
[38] ImatinibGrade 2 liver toxicity: case report
Reactions Weekly, 2019, 1776 (1) : 231 - 231
[39] AntineoplasticsInterstitial lung disease, bone marrow suppression and lack of efficacy: case report
Reactions Weekly, 2025, 2051 (1) : 36 - 36
[40] Irinotecan/lobaplatinSevere bone marrow suppression, high fever and diarrhoea: case report
Reactions Weekly, 2018, 1683 (1) : 392 - 392

← 1 2 3 4 5 →